|сгенерировать QR код
Открытый доступ
Только для подписчиков
Поражение почек при COVID-19. Обзор литературы
https://doi.org/10.36485/1561-6274-2025-29-1-19-34
EDN: FPLXPE
Аннотация
Коронавирус превратился в глобальную угрозу здоровью из-за его ускоренного географического распространения за последние два десятилетия. В этой статье рассматривается текущее состояние знаний о происхождении, передаче, диагностике и коронавирусной болезни 2019 года (COVID-19). Хотя COVID-19 в первую очередь является респираторным заболеванием, почки могут быть в числе органов-мишеней заражения коронавирусом 2-го тяжелого острого респираторного синдрома (SARS-COV-2). Независимо от исходной функции почек, острое повреждение почек является распространенным осложнением COVID-19, связанным с повышенной заболеваемостью и смертностью. Чаще всего COVID-19 вызывает острый канальцевый некроз; однако в некоторых случаях также были задокументированы коллапсирующий фокально-сегментарный гломерулосклероз и прямой вирусный тропизм почек. ОПП, вторичное по отношению к COVID-19, имеет многофакторное происхождение. Приведенные в обзоре данные помогут понять особенности развития и течения острого повреждение почек у пациентов с COVID-19, особенно при длительном течении вирусной инфекции.
Об авторе
Елена Николаевна Головина
Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского, кафедра трансплантологии, нефрологии и искусственных органов
Россия
Россия
Головина Елена Николаевна, аспирант заочного обучения,
129110, Москва, ул. Щепкина, д. 61/2.
Тел.: 8(916)537-47-11.
Список литературы
1. Ertuğlu LA, Kanbay A, Afşar B, Elsürer Afşar R, Kanbay M. COVID-19 and acute kidney injury. Tuberk Toraks 2020 Dec;68(4):407–418. English. doi: 10.5578/tt.70010
2. Deng M, Qi Y, Deng L, Wang H, Xu Y, Li Z, Meng Z, Tang J, Dai Z. Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study. Obesity (Silver Spring) 2020 Oct;28(10):1815–1825. doi: 10.1002/oby.22943
3. Sabaghian T, Rommasi F, Omidi F, Hajikhani B, Nasiri MJ, Mirsaeidi M. COVID-19 in patients with and without acute kidney injury. Bratisl Lek Listy 2022;123(5):382–380. doi: 10.4149/BLL_2022_059
4. Burtey S, Sallée M. Les atteintes rénales de la COVID-19 [Kidney damage in COVID-19]. Nephrol Ther 2021 Aug;17(4):203–207. French. doi: 10.1016/j.nephro.2021.06.002
5. Paules CI, Marston HD, Fauci AS. Coronavirus InfectionsMore Than Just the Common Cold. JAMA 2020 Feb 25;323(8):707–708. doi: 10.1001/jama.2020.0757
6. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020 Apr;92(4):401–402. doi: 10.1002/jmv.25678
7. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 Mar;579(7798):270–273. doi: 10.1038/ s41586-020-2012-7. Epub 2020 Feb 3. Erratum in: Nature 2020 Dec;588(7836):E6. doi: 10.1038/s41586-020-2951-z
8. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses 2019 Jan 14;11(1):59. doi: 10.3390/v11010059
9. Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect 2016 Mar;92(3):235–250. doi: 10.1016/j.jhin.2015.08.027
10. Gao H, Yao H, Yang S, Li L. From SARS to MERS: evidence and speculation. Front Med 2016 Dec;10(4):377–382. doi: 10.1007/s11684-016-0466-7
11. Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am 2019 Dec;33(4):869–889. doi: 10.1016/j.idc.2019.07.001
12. Monaghan NP. Emerging infections – implications for dental care. Br Dent J 2016 Jul 8;221(1):13–15. doi: 10.1038/sj.bdj.2016.486
13. Xiao S, Li Y, Sung M, Wei J, Yang Z. A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea. Indoor Air 2018 Jan;28(1):51–63. doi: 10.1111/ina.12430
14. Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol 2020; 92: 433–440. https://doi.org/10.1002/jmv.25682
15. Lau SKP, Wong ACP, Zhang L, Luk HKH, Kwok JSL, Ahmed SS, Cai JP, Zhao PSH, Teng JLL, Tsui SKW, Yuen KY, Woo PCY. Novel Bat Alphacoronaviruses in Southern China Support Chinese Horseshoe Bats as an Important Reservoir for Potential Novel Coronaviruses. Viruses 2019 May 7;11(5):423. doi: 10.3390/v11050423
16. Hui DS. Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). Clin Chest Med 2017 Mar;38(1):71–86. doi: 10.1016/j.ccm.2016.11.007
17. Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014 Sep-Oct;12(5):422–428. doi: 10.1016/j.tmaid.2014.06.007
18. Chen X, Wu Yu, Fang Yi. An integrated and automated nanotechnology-based detection system for infectious pathogens from sample input to result. Nanoscience and Nanotechnology Letters 2018; 10:1423–1428. doi: 10.1166/nnl.2018.2802
19. Crameri G, Durr PA, Barr J, Yu M, Graham K, Williams OJ, Kayali G, Smith D, Peiris M, Mackenzie JS, Wang LF. Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spread. One Health 2015 Nov 2;1:76–82. doi: 10.1016/j.onehlt.2015.10.003
20. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 2020 Apr;92(4):441–447. doi: 10.1002/jmv.25689
21. Li X, Zai J, Wang X, Li Y. Potential of large "first generation" human-to-human transmission of 2019-nCoV. J Med Virol 2020 Apr;92(4):448–454. doi: 10.1002/jmv.25693
22. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020 Feb;91:264–266. doi: 10.1016/j.ijid.2020.01.009
23. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016 Aug;14(8):523–534. doi: 10.1038/nrmicro.2016.81
24. Gong SR, Bao LL. The battle against SARS and MERS coronaviruses: Reservoirs and Animal Models. Animal Model Exp Med 2018 Jul 28;1(2):125–133. doi: 10.1002/ame2.12017
25. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 Apr 30;382(18):1708–1720. doi: 10.1056/NEJMoa2002032
26. National Health Commission of the People's Republic of China. New Program for the Prevention and Control of Coronavirus Pneumonia (Sixth Edition).http://www.nhc.gov.cn/jkj/s3577/202003/4856d5b0458141fa9f376853224d41d7/files/4132bf035bc242478a6eaf157eb0d979.pdf
27. Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol 2020 Apr;5(4):335–337. doi: 10.1016/S2468-1253(20)30048-0
28. Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, Benachi A, De Luca D. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020 Jul 14;11(1):3572. doi: 10.1038/s41467-020-17436-6
29. (RIVM) RvVeM. COVID-19: Advice for residents of NoordBrabant. [COVID-19: Advice for residents of Noord-Brabant]. Bilthoven: RIVM; 2020
30. Reusken CB, Buiting A, Bleeker-Rovers C, Diederen B, Hooiveld M, Friesema I, Koopmans M, Kortbeek T, Lutgens SP, Meijer A, Murk JL, Overdevest I, Trienekens T, Timen A, Van den Bijllaardt W, Van Dissel J, Van Gageldonk-Lafeber A, Van der Vegt D, Wever PC, Van der Hoek W, Kluytmans J. Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020. Euro Surveill 2020 Mar;25(12):2000334. doi: 10.2807/1560-7917.ES.2020.25.12.2000334
31. CBC News Community transmission of COVID-19 detected in Winnipeg, public health of Accessed May 25, 2020.ficials say. https://www.cbc.ca/news/canada/manitoba/manitoba-covid-19briefing-1.5517379
32. Community transmission of COVID-19 identified in Teton County, more cases in Custer and Bonneville. https://localnews8.com/health/coronavirus/2020/04/01/community-transmission-ofcovid-19-identified-in-teton-county-more-cases-in-custer-andbonneville-counties/. Accessed May 25, 2020
33. Chowell G, Abdirizak F, Lee S et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med 2015;13: 210. https://doi.org/10.1186/s12916015-0450-0
34. NBC News. Healthcare workers in Spain and Italy 'overloaded' as more of them catch coronavirus. https://www.nbcnews.com/news/world/medical-workers-spain-italy-overloaded-morethem-catch-coronavirus-n1170721. Accessed May 25, 2020
35. AJazeera News. Thousands of medical staff infected with coronavirus in Italy. https://www.aljazeera.com/news/2020/03/rising-number-medical-staff-infected-coronavirus-italy-200318183939314.html. Accessed May 25, 2020
36. Nakoti M, Ciocca A, Giupponi A et al . At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparedness and mitigation. NEJM Catalyst Innovations in Health Care Delivery, 1(2)
37. Spina S, Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R. The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy. Lancet 2020 Mar 14;395(10227):e49– e50. doi: 10.1016/S0140-6736(20)30493-1
38. NEW YORK TIMES. Nurses are dying, doctors are getting sick, and panic is rising on the virus’s front lines. https://www.nytimes.com/2020/03/30/nyregion/ny-coronavirus-doctors-sick.html. Accessed May 25, 2020
39. Phan MVT, Ngo Tri T, Hong Anh P, Baker S, Kellam P, Cotten M. Identification and characterization of Coronaviridae genomes from Vietnamese bats and rats based on conserved protein domains. Virus Evol 2018 Dec 15;4(2):vey035. doi: 10.1093/ve/vey035
40. Abduljalil JM, Abduljalil BM. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes New Infect 2020 Mar 31;35:100672. doi: 10.1016/j.nmni.2020.100672
41. Parsamanesh N, Pezeshgi A, Hemmati M, Jameshorani M, Saboory E. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19. Int J Neurosci 2022 Sep;132(9):917–924. doi: 10.1080/00207454.2020.1849193
42. Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A, Atif SM, Hariprasad G, Hasan GM, Hassan MI. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim Biophys Acta Mol Basis Dis 2020 Oct 1;1866(10):165878. doi: 10.1016/j.bbadis.2020.165878
43. Krichel B, Falke S, Hilgenfeld R, Redecke L, Uetrecht C. Processing of the SARS-CoV pp1a/ab nsp7-10 region. Biochem J 2020 Mar 13;477(5):1009–1019. doi: 10.1042/BCJ20200029
44. Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep 2020 Jun;19:100682. doi: 10.1016/j.genrep.2020.100682
45. Mu J, Xu J, Zhang L, Shu T, Wu D, Huang M, Ren Y, Li X, Geng Q, Xu Y, Qiu Y, Zhou X. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells. Sci China Life Sci 2020 Sep;63(9):1413–1416. doi: 10.1007/s11427-020-1692-1
46. Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr 2020 Jul-Aug;14(4):407–412. doi: 10.1016/j.dsx.2020.04.020
47. Voss D, Pfefferle S, Drosten C, Stevermann L, Traggiai E, Lanzavecchia A, Becker S. Studies on membrane topology, Nglycosylation and functionality of SARS-CoV membrane protein. Virol J 2009 Jun 18;6:79. doi: 10.1186/1743-422X-6-79
48. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 Mar;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
49. Kang S, Yang M, Hong Z, Zhang L, Huang Z, Chen X, He S, Zhou Z, Zhou Z, Chen Q, Yan Y, Zhang C, Shan H, Chen S. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B 2020 Jul;10(7):1228–1238. doi: 10.1016/j.apsb.2020.04.009
50. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol 2020 Mar 17;94(7):e00127–20. doi: 10.1128/JVI.00127-20
51. Chu DKW, Hui KPY, Perera RAPM, Miguel E, Niemeyer D, Zhao J, Channappanavar R, Dudas G, Oladipo JO, Traoré A, Fassi-Fihri O, Ali A, Demissié GF, Muth D, Chan MCW, Nicholls JM, Meyerholz DK, Kuranga SA, Mamo G, Zhou Z, So RTY, Hemida MG, Webby RJ, Roger F, Rambaut A, Poon LLM, Perlman S, Drosten C, Chevalier V, Peiris M. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci U S A 2018 Mar 20;115(12):3144–3149. doi: 10.1073/pnas.1718769115
52. Lau SK, Li KS, Tsang AK, Lam CS, Ahmed S, Chen H, Chan KH, Woo PC, Yuen KY. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 2013 Aug;87(15):8638–8650. doi: 10.1128/JVI.01055-13
53. Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis 2021 May;40(5):905–919. doi: 10.1007/s10096-020-04138-6
54. Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, Dahal S, Kumar H, Kv D. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 2020 Dec;96(1142):753–758. doi: 10.1136/postgradmedj-2020-138234
55. Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Feng Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta 2020 Jun;505:172–175. doi: 10.1016/j.cca.2020.03.009
56. Eigner U, Reucher S, Hefner N, Staffa-Peichl S, Kolb M, Betz U, Holfelder M, Spier G, Pfefferle S, Lütgehetmann M. Clinical evaluation of multiplex RT-PCR assays for the detection of influenza A/B and respiratory syncytial virus using a high throughput system. J Virol Methods 2019 Jul;269:49–54. doi: 10.1016/j.jviromet.2019.03.015
57. Zhu X, Wang X, Han L, Chen T, Wang L, Li H, Li S, He L, Fu X, Chen S, Xing M, Chen H, Wang Y. Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19. Biosens Bioelectron 2020 Oct 15;166:112437. doi: 10.1016/j.bios.2020.112437
58. Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L. Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. AJR Am J Roentgenol 2020 May;214(5):1078–1082. doi: 10.2214/AJR.20.22969
59. Liakopoulos V, Roumeliotis S, Papachristou S, Papanas N. COVID-19 and the kidney: time to take a closer look. Int Urol Nephrol 2022 May;54(5):1053–1057. doi: 10.1007/s11255-021-02976-7
60. Majumder J, Minko T. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS J 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2
61. Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 2021 May;14(5):601–621. doi: 10.1080/17512433.2021.1902303.
62. Birkelo BC, Pannu N, Siew ED. Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient. Clin J Am Soc Nephrol 2022 May;17(5):717–735. doi: 10.2215/CJN.14181021
63. Thongprayoon C, Hansrivijit P, Kovvuru K, Kanduri SR, Torres-Ortiz A, Acharya P, Gonzalez-Suarez ML, Kaewput W, Bathini T, Cheungpasitporn W. Diagnostics, Risk Factors, Treatment and Outcomes of Acute Kidney Injury in a New Paradigm. J Clin Med 2020 Apr 13;9(4):1104. doi: 10.3390/jcm9041104
64. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120(4):c179–184. doi: 10.1159/000339789
65. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 Apr 30;382(18):1708–1720. doi: 10.1056/NEJMoa2002032
66. Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, Swaminathan S; COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group. Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. J Am Soc Nephrol 2020 Jul;31(7):1380–1383. doi: 10.1681/ASN.2020040419
67. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020 May;97(5):829–838. doi: 10.1016/j.kint.2020.03.005
68. Cheng Y, Luo R, Wang X, Wang K, Zhang N, Zhang M, Wang Z, Dong L, Li J, Zeng R, Yao Y, Ge S, Xu G. The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019. Clin J Am Soc Nephrol 2020 Oct 7;15(10):1394–1402. doi: 10.2215/CJN.04650420
69. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, Hazzan AD, Fishbane S, Jhaveri KD; Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020 Jul;98(1):209–218. doi: 10.1016/j.kint.2020.05.006
70. Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, Hochman BR, Salazar-Schicchi J, Yip NH, Brodie D, O'Donnell MR. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020 Jun 6;3 95(10239):1763–1770. doi: 10.1016/S01406736(20)31189-2
71. Ng JH, Hirsch JS, Hazzan A, Wanchoo R, Shah HH, Malieckal DA, Ross DW, Sharma P, Sakhiya V, Fishbane S, Jhaveri KD; Northwell Nephrology COVID-19 Research Consortium. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis 2021 Feb;77(2):204–215.e1. doi: 10.1053/j.ajkd.2020.09.002
72. Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE; and the STOP-COVID Investigators. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. J Am Soc Nephrol 2021 Jan;32(1):161–176. doi: 10.1681/ASN.2020060897
73. Carlson N, Nelveg-Kristensen KE, Freese Ballegaard E, Feldt-Rasmussen B, Hornum M, Kamper AL, Gislason G, TorpPedersen C. Increased vulnerability to COVID-19 in chronic kidney disease. J Intern Med 2021 Jul;290(1):166–178. doi: 10.1111/joim.13239. Epub 2021 Feb 10. PMID: 33452733; PMCID: PMC8014284
74. Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, Cantaluppi V. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021 Nov;17(11):751–764. doi: 10.1038/s41581-021-00452-0
75. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013 Jul 27;382(9889):339–352. doi: 10.1016/S0140-6736(13)60595-4
76. Santoriello D, Khairallah P, Bomback AS, Xu K, Kudose S, Batal I, Barasch J, Radhakrishnan J, D'Agati V, Markowitz G. Postmortem Kidney Pathology Findings in Patients with COVID-19. J Am Soc Nephrol 2020 Sep;31(9):2158–2167. doi: 10.1681/ASN.2020050744
77. Kudose S, Batal I, Santoriello D, Xu K, Barasch J, Peleg Y, Canetta P, Ratner LE, Marasa M, Gharavi AG, Stokes MB, Markowitz GS, D'Agati VD. Kidney Biopsy Findings in Patients with COVID-19. J Am Soc Nephrol 2020 Sep;31(9):1959–1968. doi: 10.1681/ASN.2020060802
78. Sharma P, Uppal NN, Wanchoo R, Shah HH, Yang Y, Parikh R, Khanin Y, Madireddy V, Larsen CP, Jhaveri KD, Bijol V; Northwell Nephrology COVID-19 Research Consortium. COVID19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. J Am Soc Nephrol 2020 Sep;31(9):1948–1958. doi: 10.1681/ASN.2020050699
79. Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir M, Chughtai A, Xie L, Gimenez JM, Sandow TA, Lusco MA, Yang H, Acheampong E, Rosales IA, Colvin RB, Fogo AB, Velez JCQ. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype. J Am Soc Nephrol 2020 Aug;31(8):1688–1695. doi: 10.1681/ASN.2020050558
80. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020 Jul;98(1):219–227. doi: 10.1016/j.kint.2020.04.003
81. Werion A, Belkhir L, Perrot M, Schmit G, Aydin S, Chen Z, Penaloza A, De Greef J, Yildiz H, Pothen L, Yombi JC, Dewulf J, Scohy A, Gérard L, Wittebole X, Laterre PF, Miller SE, Devuyst O, Jadoul M, Morelle J; Cliniques universitaires Saint-Luc (CUSL) COVID-19 Research Group. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int 2020 Nov;98(5):1296–1307. doi: 10.1016/j.kint.2020.07.019
82. O'Reilly P, Tolwani A. Renal replacement therapy III: IHD, CRRT, SLED. Crit Care Clin 2005 Apr;21(2):367–378. doi: 10.1016/j.ccc.2005.01.004
83. Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 2012 Dec 27;367(26):2505–2514. doi: 10.1056/NEJMct1206045
84. Cerdá J, Ronco C. Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial 2009 Mar-Apr;22(2):114–22. doi: 10.1111/j.1525-139X.2008.00549.x
85. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C; ADQI Workgroup. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002 Nov;62(5):1855–1863. doi: 10.1046/j.1523-1755.2002.00613.x
86. Cerda J, Sheinfeld G, Ronco C. Fluid overload in critically ill patients with acute kidney injury. Blood Purif 2010;29(4):331–338. doi: 10.1159/000287776
87. Schwenger V, Weigand MA, Hoffmann O, Dikow R, Kihm LP, Seckinger J, Miftari N, Schaier M, Hofer S, Haar C, Nawroth PP, Zeier M, Martin E, Morath C. Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury – a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care 2012 Jul 27;16(4):R140. doi: 10.1186/cc11445
88. Villa G, Neri M, Bellomo R, Cerda J, De Gaudio AR, De Rosa S, Garzotto F, Honore PM, Kellum J, Lorenzin A, Payen D, Ricci Z, Samoni S, Vincent JL, Wendon J, Zaccaria M, Ronco C; Nomenclature Standardization Initiative (NSI) Alliance. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications. Crit Care 2016 Oct 10;20(1):283. doi: 10.1186/s13054-016-1456-5
89. Lins RL, Elseviers MM, Van der Niepen P, Hoste E, Malbrain ML, Damas P, Devriendt J; SHARF investigators. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant 2009 Feb;24(2):512–518. doi: 10.1093/ndt/gfn560
90. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006 Jul 29;368(9533):379–385. doi: 10.1016/S0140-6736(06)69111-3
91. Nash DM, Przech S, Wald R, O'Reilly D. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care 2017 Oct;41:138–144. doi: 10.1016/j.jcrc.2017.05.002
92. Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care 2012 Aug 6;16(4):R146. doi: 10.1186/cc11458
93. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000 Jul 1;356(9223):26–30. doi: 10.1016/S0140-6736(00)02430-2
94. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008 Jul 3;359(1):7–20
95. RENAL Replacement Therapy Study Investigators; Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009 Oct 22;361(17):1627–1638. doi: 10.1056/NEJMoa0902413
96. Clark E, Molnar AO, Joannes-Boyau O, Honoré PM, Sikora L, Bagshaw SM. High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care 2014 Jan 8;18(1):R7. doi: 10.1186/cc13184
97. Combes A, Bréchot N, Amour J, Cozic N, Lebreton G, Guidon C, Zogheib E, Thiranos JC, Rigal JC, Bastien O, Benhaoua H, Abry B, Ouattara A, Trouillet JL, Mallet A, Chastre J, Leprince P, Luyt CE. Early High-Volume Hemofiltration versus Standard Care for Post-Cardiac Surgery Shock. The HEROICS Study. Am J Respir Crit Care Med 2015 Nov 15;192(10):1179–1190. doi: 10.1164/rccm.201503-0516OC
98. Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D; AKIKI Study Group. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. N Engl J Med 2016 Jul 14;375(2):122–133. doi: 10.1056/NEJMoa1603017
99. Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyère R, Lebert C, Bohé J, Badie J, Eraldi JP, Rigaud JP, Levy B, Siami S, Louis G, Bouadma L, Constantin JM, Mercier E, Klouche K, du Cheyron D, Piton G, Annane D, Jaber S, van der Linden T, Blasco G, Mira JP, Schwebel C, Chimot L, Guiot P, Nay MA, Meziani F, Helms J, Roger C, Louart B, Trusson R, Dargent A, Binquet C, Quenot JP; IDEAL-ICU Trial Investigators and the CRICS TRIGGERSEP Network. Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. N Engl J Med 2018 Oct 11;379(15):1431–1442. doi: 10.1056/NEJMoa1803213
100. Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstädt H, Boanta A, Gerß J, Meersch M. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. JAMA 2016 May 24-31;315(20):2190–2199. doi: 10.1001/jama.2016.5828
101. Ren A, Li Z, Zhang X, Deng R, Ma Y. Optimal timing of initiating CRRT in patients with acute kidney injury after liver transplantation. Ann Transl Med 2020 Nov;8(21):1361. doi: 10.21037/atm-20-2352
102. Gaudry S, Hajage D, Martin-Lefevre L, Louis G, Moschietto S, Titeca-Beauport D, La Combe B, Pons B, de Prost N, Besset S, Combes A, Robine A, Beuzelin M, Badie J, Chevrel G, Reignier J, Bohé J, Coupez E, Chudeau N, Barbar S, Vinsonneau C, Forel JM, Thevenin D, Boulet E, Lakhal K, Aissaoui N, Grange S, Leone M, Lacave G, Nseir S, Poirson F, Mayaux J, Asehnoune K, Geri G, Klouche K, Thiery G, Argaud L, Ricard JD, Quenot JP, Dreyfuss D. The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trial. Trials 2019 Dec 16;20(1):726. doi: 10.1186/s13063-019-3774-9
103. STARRT-AKI Investigators. STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury: Study Protocol for a Multi-National, Multi-Center, Randomized Controlled Trial. Can J Kidney Health Dis 2019 Jun 10;6:2054358119852937. doi: 10.1177/2054358119852937
104. Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 2020 Dec;16(12):747–764. doi: 10.1038/s41581-02000356-5. Epub 2020 Oct 15. Erratum in: Nat Rev Nephrol. 2020 Dec;16(12):765. doi: 10.1038/s41581-020-00372-5
105. Nugent J, Aklilu A, Yamamoto Y, Simonov M, Li F, Biswas A, Ghazi L, Greenberg H, Mansour G, Moledina G, Wilson FP. Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19. JAMA Netw Open 2021 Mar 1;4(3):e211095. doi: 10.1001/jamanetworkopen.2021.1095. Erratum in: JAMA Netw Open. 2021 Apr 1;4(4):e2111225. doi: 10.1001/jamanetworkopen.2021.11225
106. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020 May;97(5):829–838. doi: 10.1016/j.kint.2020.03.005
107. Zhou F, Yu T, Du R et al. Clinical course and mortality risk factors of adult patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: P1054–1062
108. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, Hazzan AD, Fishbane S, Jhaveri KD; Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020 Jul;98(1):209–218. doi: 10.1016/j.kint.2020.05.006
109. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, Chang BP, Chau KH, Choi JJ, Gavin N, Goyal P, Mills AM, Patel AA, Romney MS, Safford MM, Schluger NW, Sengupta S, Sobieszczyk ME, Zucker JE, Asadourian PA, Bell FM, Boyd R, Cohen MF, Colquhoun MI, Colville LA, de Jonge JH, Dershowitz LB, Dey SA, Eiseman KA, Girvin ZP, Goni DT, Harb AA, Herzik N, Householder S, Karaaslan LE, Lee H, Lieberman E, Ling A, Lu R, Shou AY, Sisti AC, Snow ZE, Sperring CP, Xiong Y, Zhou HW, Natarajan K, Hripcsak G, Chen R. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 2020 May 29;369:m1996. doi: 10.1136/bmj.m1996
110. ICNARC. ICNARC report on COVID-19 in intensive care units May 8, 2020
Рецензия
Для цитирования:
Головина Е.Н. Поражение почек при COVID-19. Обзор литературы. Нефрология. 2025;29(1):19-34. https://doi.org/10.36485/1561-6274-2025-29-1-19-34. EDN: FPLXPE
For citation:
Golovina E.N. Kidney damage in COVID-19. Literature review. Nephrology (Saint-Petersburg). 2025;29(1):19-34. (In Russ.) https://doi.org/10.36485/1561-6274-2025-29-1-19-34. EDN: FPLXPE
Просмотров:
124
Послать статью по эл. почте 